Vara nets first CE mark for autonomous AI breast cancer screening tool
The autonomous triage system’s European market authorisation comes as AI becomes increasingly embedded into the cancer screening paradigm.
Therapy Area
Women’s health attracted record equity in 2025 as companies share capital
Novocure’s Optune Gio fails to show benefit at earlier stage
Parkinson’s disease: neuromodulation and the search for disease modification
Roche’s Elecsys NfL test earns CE mark for multiple sclerosis detection
Non-invasive diagnostics in endometriosis: at the cusp of a turning point
Daiichi and GAIA join forces to commercialise digital cardiovascular therapy
Guardant Health acquires MetaSight amid positive 2026 financial outlook
